Cellectis S.A.

€1.00As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALCLSHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (24.20%)
Div yield —
ROE (94.54%)
Biotechnology
Beta (5Y) 2.94
PE TTM —
TSR TTM (67.42%)
Mkt cap €73.06M
ROIC (23.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€1.22
21.20%
(78.29%)
Hold 5|8|12|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
30.70%
38.87%
40.22%
35.01%
Revenue$M
3.401
3.500
3.698
3.602
3.21%
4.42%
7.59%
5.21%
Peers (US$82.04M)
Cap (US$)
PE
102.3M
—
73.69M
—
61.82M
—
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
2.517
(0.139)
(0.126)
EBIT/Intx
0.861
2.621
2.779
Own earn%
(15.49)
(185.81)
(150.39)
Sh yield%
12.92
45.28
45.24
Owners
Insiders/Inst%
11.87
23.46
Short interest%
5.83
SBC / revenue%
3.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
22–28
$1 testx
−0.1
Incr. ROIC%
0